"With an increasing number of similar GLP-1 drugs now being used in clinical practice, for conditions ranging from type 2 diabetes and obesity to kidney disease, our findings highlight the potential for these existing drugs to be repurposed to treat the risk of 'no-reflow' in heart attack patients, offering a potentially life-saving solution," said University College London Professor David Atwell
Additional clinical studies involving liraglutide and dulaglutide are ongoing
The capsule format (5mg per capsule, 60 capsules) provides pre-measured, consistent dosing units suited to oral administration research protocols, while the powder format supports custom solution preparation for in vitro, parenteral, or variable-dose experimental designs
Creatine is one of the most researched, affordable ways to fight back
Hosit is one of the Top 10 Methylcobalamin Injection Brands in India which is highly recommended to B12 deficiency patients
Can I take Aspirin and Lansoprazole together